ClinicalTrials.govpublic full text
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
melanoma, immune-related adverse event, immune checkpoint inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 872481
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.